142 related articles for article (PubMed ID: 11709707)
1. Malolactomycin D, a potent inhibitor of transcription controlled by the Ras responsive element, inhibits Ras-mediated transformation activity with suppression of MMP-1 and MMP-9 in NIH3T3 cells.
Futamura M; Kamiya S; Tsukamoto M; Hirano A; Monden Y; Arakawa H; Nishimura S
Oncogene; 2001 Oct; 20(46):6724-30. PubMed ID: 11709707
[TBL] [Abstract][Full Text] [Related]
2. Roxithromycin inhibits tumor necrosis factor-alpha-induced matrix metalloproteinase-1 expression through regulating mitogen-activated protein kinase phosphorylation and Ets-1 expression.
Oyama T; Matsushita K; Sakuta T; Tokuda M; Tatsuyama S; Nagaoka S; Torii M
J Periodontal Res; 2007 Feb; 42(1):53-61. PubMed ID: 17214640
[TBL] [Abstract][Full Text] [Related]
3. Activation of fibroblast collagenase-1 expression by tumor cells of squamous cell carcinomas is mediated by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase-2.
Westermarck J; Li S; Jaakkola P; Kallunki T; Grénman R; Kähäri VM
Cancer Res; 2000 Dec; 60(24):7156-62. PubMed ID: 11156425
[TBL] [Abstract][Full Text] [Related]
4. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells.
Ulkü AS; Schäfer R; Der CJ
Mol Cancer Res; 2003 Dec; 1(14):1077-88. PubMed ID: 14707291
[TBL] [Abstract][Full Text] [Related]
5. Ras/MEK pathway is required for NGF-induced expression of tyrosine hydroxylase gene.
Suzuki T; Kurahashi H; Ichinose H
Biochem Biophys Res Commun; 2004 Mar; 315(2):389-96. PubMed ID: 14766220
[TBL] [Abstract][Full Text] [Related]
6. Doxycycline inhibits TGF-beta1-induced MMP-9 via Smad and MAPK pathways in human corneal epithelial cells.
Kim HS; Luo L; Pflugfelder SC; Li DQ
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):840-8. PubMed ID: 15728539
[TBL] [Abstract][Full Text] [Related]
7. SCH 51344 inhibits ras transformation by a novel mechanism.
Kumar CC; Prorock-Rogers C; Kelly J; Dong Z; Lin JJ; Armstrong L; Kung HF; Weber MJ; Afonso A
Cancer Res; 1995 Nov; 55(21):5106-17. PubMed ID: 7585559
[TBL] [Abstract][Full Text] [Related]
8. SH2 domain containing protein tyrosine phosphatase 2 regulates concanavalin A-dependent secretion and activation of matrix metalloproteinase 2 via the extracellular signal-regulated kinase and p38 pathways.
Ruhul Amin AR; Oo ML; Senga T; Suzuki N; Feng GS; Hamaguchi M
Cancer Res; 2003 Oct; 63(19):6334-9. PubMed ID: 14559821
[TBL] [Abstract][Full Text] [Related]
9. Phenyl N-tert-butylnitrone down-regulates interleukin-1 beta-stimulated matrix metalloproteinase-13 gene expression in human chondrocytes: suppression of c-Jun NH2-terminal kinase, p38-mitogen-activated protein kinase and activating protein-1.
Ahmed S; Rahman A; Hasnain A; Goldberg VM; Haqqi TM
J Pharmacol Exp Ther; 2003 Jun; 305(3):981-8. PubMed ID: 12626640
[TBL] [Abstract][Full Text] [Related]
10. Treatment of epigallocatechin-3-gallate inhibits matrix metalloproteinases-2 and -9 via inhibition of activation of mitogen-activated protein kinases, c-jun and NF-kappaB in human prostate carcinoma DU-145 cells.
Vayalil PK; Katiyar SK
Prostate; 2004 Apr; 59(1):33-42. PubMed ID: 14991864
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of collagenase-3 (MMP-13) expression in transformed human keratinocytes by interferon-gamma is associated with activation of extracellular signal-regulated kinase-1,2 and STAT1.
Ala-aho R; Johansson N; Grénman R; Fusenig NE; López-Otín C; Kähäri VM
Oncogene; 2000 Jan; 19(2):248-57. PubMed ID: 10645003
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1beta induces MMP-9 expression via p42/p44 MAPK, p38 MAPK, JNK, and nuclear factor-kappaB signaling pathways in human tracheal smooth muscle cells.
Liang KC; Lee CW; Lin WN; Lin CC; Wu CB; Luo SF; Yang CM
J Cell Physiol; 2007 Jun; 211(3):759-70. PubMed ID: 17311279
[TBL] [Abstract][Full Text] [Related]
13. ERK1/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP-1: Involvement of the ras dependent pathway.
Moon SK; Cha BY; Kim CH
J Cell Physiol; 2004 Mar; 198(3):417-27. PubMed ID: 14755547
[TBL] [Abstract][Full Text] [Related]
14. IL-1 beta promotes A549 cell migration via MAPKs/AP-1- and NF-kappaB-dependent matrix metalloproteinase-9 expression.
Lin CC; Kuo CT; Cheng CY; Wu CY; Lee CW; Hsieh HL; Lee IT; Yang CM
Cell Signal; 2009 Nov; 21(11):1652-62. PubMed ID: 19616091
[TBL] [Abstract][Full Text] [Related]
15. Rhein inhibits TPA-induced activator protein-1 activation and cell transformation by blocking the JNK-dependent pathway.
Lin S; Li JJ; Fujii M; Hou DX
Int J Oncol; 2003 Apr; 22(4):829-33. PubMed ID: 12632075
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH
Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899
[TBL] [Abstract][Full Text] [Related]
17. p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells.
Kim MS; Lee EJ; Kim HR; Moon A
Cancer Res; 2003 Sep; 63(17):5454-61. PubMed ID: 14500381
[TBL] [Abstract][Full Text] [Related]
18. Independent role of p38 and ERK1/2 mitogen-activated kinases in the upregulation of matrix metalloproteinase-1.
Brauchle M; Glück D; Di Padova F; Han J; Gram H
Exp Cell Res; 2000 Jul; 258(1):135-44. PubMed ID: 10912795
[TBL] [Abstract][Full Text] [Related]
19. IL-1 and TNF induction of matrix metalloproteinase-3 by c-Jun N-terminal kinase in trabecular meshwork.
Hosseini M; Rose AY; Song K; Bohan C; Alexander JP; Kelley MJ; Acott TS
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1469-76. PubMed ID: 16565381
[TBL] [Abstract][Full Text] [Related]
20. p38 MAP kinase regulates rapid matrix metalloproteinase-9 release from eosinophils.
Wiehler S; Cuvelier SL; Chakrabarti S; Patel KD
Biochem Biophys Res Commun; 2004 Mar; 315(2):463-70. PubMed ID: 14766231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
